Eligibility of rheumatoid arthritis patients for anti-TNF-α therapy according to the 2005 recommendations of the French and British Societies for Rheumatology

摘要

Objectives. Several anti-TNF-α prescription guidelines in RA have been published, among which those issued by the British (BSR) and French (SFR) Societies for Rheumatology in 2005 are the most comprehensive. Objectives of the PRISME II survey were to assess and compare eligibility for anti-TNF-α therapy of RA patients consulting their usual rheumatologist according to (i) the SFR and BSR guidelines and (ii) the rheumatologist's opinion.